Vedanta Capital
Fund of fundsNew York · Seed–Late Stage · 9 people tracked
Investment thesis
Vedanta believes that exceptional returns in venture capital are generated by visionary, market-altering companies that are nurtured by a select group of top-tier venture firms. This creates a virtuous cycle where leading entrepreneurs naturally gravitate toward top-performing venture firms. The firm seeks to balance the pursuit of persistent returns with identification of talented emerging managers, leveraging its partners' 30+ years of collective experience to deliver superior returns for limited partners.
Source: firm website, verified Jul 21, 2026.
Team · 9 people
from the firm's websiteInvestments · 49 tracked
founders shown can be your intro pathOptical telecommunications equipment provider
Electronic Design Automation software for complex chip design
Security processor company developing hardware-based security technologies with per-system AI
Develops dual-action cancer therapies combining targeted treatments with tumor modulators
Developer and manufacturer of medical technologies for respiratory and neuromuscular diseases
Indian café chain operating in six countries
Virtual reality telerobotics platform
Biotechnology company discovering and commercializing medicines for cancer and inflammatory disorders
Pharmaceutical company developing novel approach to Alzheimer's disease
Retailer of consumer electronics and technology products
Cloud-based healthcare analytics solutions
Holistic platform for chronic disease management
Trusted partner for specialty chemicals
Healthcare services and technology
Mall-based clothing retailer for teenagers
Company focusing on genetic research in cancer detection
Biotechnology startup focused on cell therapy and personalized immunotherapy
Solutions provider for intelligence, cyber and counterterrorism communities
Small business lending platform using cutting-edge technologies and automation
Global medical technology company developing patient monitoring technologies
Prepaid wireless service provider
Supplier of bioanalytical measurement systems for drug discovery and life sciences research
Biotechnology company developing and commercializing immunotherapy products for cancer
Clinical-stage oncology company developing cancer treatments
Developer of optical telecommunications systems
Life sciences consulting firm and contract research organization
Retail chain of pet supplies and grooming services
Multinational corporation developing video, voice and content collaboration and communication technology
Clinical-stage pharmaceutical company developing innovative therapies
Semiconductor company developing proprietary mixed-signal integrated circuits
Improves access to affordable care through technology and delivery models
Aviation and aerospace company reducing space travel costs through reusable rockets
Biopharmaceutical company developing innovative immunotherapies for tauopathies
Next-generation gigabit router provider
Chain of beauty stores carrying cosmetics, skincare, fragrances and haircare products
Next-generation oncology company developing novel antibody-drug conjugates for haematological cancers
Operates a diverse array of network infrastructure
Power management analog and mixed-signal semiconductor company
American women's clothing retailer
Integrated biotechnology company advancing artificial intelligence applications
Frequently asked questions
- What stage does Vedanta Capital invest at?
- Vedanta Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Vedanta Capital focus on?
- Vedanta Capital focuses on Sector Agnostic.
- Where is Vedanta Capital located?
- Vedanta Capital is headquartered in New York, US.
Similar investors
500 Global's Sustainable Growth practice designs and implements sovereign-aligned strategies that unlock resilient, inclusive, and sustainable economic growth across the Global Majority—Asia, Africa, Latin America, and the Middle East. The practice bridges public priorities and private capital through ecosystem development, blended finance, and localized innovation programs addressing health, agriculture, gender, climate, and education.
a16z is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz that invests in seed through growth-stage technology companies across multiple sectors including AI, healthcare, consumer, crypto, enterprise, fintech, and gaming. The firm manages over $100 billion in assets and operates a distinctive platform model with a large team of operators supporting founders throughout their journey.
August Capital is a venture capital firm headquartered in the San Francisco Bay Area that has invested in early-stage startups across information technology since 1995. The firm manages approximately $2 billion in assets and combines capital deployment with operational support and networking assistance to help entrepreneurs build successful companies.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Balderton is a European venture capital firm that has invested in over 300 companies across all stages from seed through IPO since 2000. With €5.7 billion raised to invest, the firm provides substantial capital and hands-on operational support through its experienced partnership team and portfolio services.